Cost-Effectiveness of Single Versus Double DAIR with Antibiotic Beads for Acute Periprosthetic Joint Infections in TKA 

Description

In this insightful talk, Lesley Curwen discusses the concerning state of stem cell treatments, particularly in the context of joint and orthopedic applications. She references Professor Fares Haddad, a prominent hip and knee surgeon, who critiques the lack of substantial scientific evidence supporting these commercial medical practices. Haddad emphasizes the distinction between genuine scientific research and the premature application of unproven therapies that create false hope for patients. Examples are provided of patients suffering adverse effects from stem cell procedures, including serious infections and complications like blood clots. Curwen also touches on the regulatory challenges in the UK, where existing loopholes allow for these treatments to be marketed without stringent oversight. She shares harrowing testimonials from patients and families who have encountered life-altering consequences due to these treatments, including cases from a London clinic where patients faced severe complications. The talk raises critical ethical questions about consumer protection in the field of regenerative medicine, ultimately urging a closer look at the implications of these treatments as misleading claims proliferate in the marketplace. Curwen encourages listeners to explore her detailed reporting on the subject, which exposes the complexities and potential dangers associated with stem cell therapies.

DOI: 10.1302/3114-221835

Specialties

Conferences